qa:qa_dcx-login
A Higher Level of PCR Excellence
To know Cepheid is to know our spirit of innovation. It is what compelled us to re-invent the industry’s approach to molecular diagnostic testing. Our founders envisioned A Better Way for healthcare professionals to access the accuracy of real-time PCR in a faster, more flexible, scalable, and user-friendly format — one that could extend beyond the laboratory. Our commitment to improve patient care with faster, more accurate answers is at the heart of everything we do. We call it the PCRplus advantage.
Our Mission
Delivering A Better Way to improve patient outcomes by enabling access to molecular diagnostic testing everywhere.
Our Vision
To be the leading provider of seamlessly connected diagnostic solutions.
Associate Promise
Working at Cepheid is MORE than a career.
Explore opportunities to perform groundbreaking work.
Learn more about Cepheid’s Track Record of Innovation.
“Cepheid has a long history of quickly developing and delivering tests that address urgent public health issues as they emerge.”
His rebus in Italiam Caesari nuntiatis, cum iam ille urbanas res virtute Cn. Pompei commodiorem in statum pervenisse intellegeret, in Transalpinam Galliam profectus est.
The GeneXpert System at the Heart of Biohazard Detection
Foreshadowing Cepheid's legacy of quickly developing tests to address urgent public health issues as they emerge, the company’s focus temporarily shifted following the U.S. terrorist attacks in 2001. In collaboration with Northrop Grumman, the GeneXpert system was at the heart of the biohazard detection system for the United States Postal Service. Launched in 2003, the program has delivered over 15 million test results with no false positives. While the biothreat aspect of Cepheid’s business grew, Cepheid quickly returned to its vision of delivering the GeneXpert system and an associated menu of diagnostic tests to the clinical market.